Daily Mail Snippet 27 August 2017
Charcot-Marie-Tooth disease (CMT) is a genetic neurological disorder that affects around 23,000 people in the UK but is little known. […]
Continue Reading
Charcot-Marie-Tooth disease (CMT) is a genetic neurological disorder that affects around 23,000 people in the UK but is little known. […]
Continue ReadingA mother who suffers from a disorder which makes feet shrink only managed to get a diagnosis after sharing symptoms […]
Continue Reading
A mum wants to raise awareness of a rare condition that saw her daughter in a wheelchair just nine months after she was diagnosed.
Continue Reading
Acceleron Pharma Inc, a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics
Continue ReadingResearch conducted at the Institute of Neurology of University College London (UCL) just published in the Proceedings of the National Academy of Sciences USA has identified a set of novel therapeutic targets for a subtype of Charcot-Marie-Tooth disease (CMT), a human condition that currently has no effective treatments.
Continue ReadingDr Andrew Shevchuk and his team from Imperial College London will investigate how mutations associated with some types of centronuclear myopathy and Charcot-Marie-Tooth disease (CMT)
Continue ReadingLast Updated: Friday 15th September, 2017